Help MAPS Complete Crucial MDMA Research
To make psychedelic therapy the next medical marijuana, MAPS needs your support.
MDMA isn’t just a party drug - it holds tremendous medical potential. We previously reported about initial research suggesting that the drug can be the key to PTSD treatments. According to Rick Doblin, the founder of MAPS, MDMA-assisted psychotherapy for the treatment of PTSD could become a reality by 2021. This is the goal, and MAPS is working hard to make it happen.
To complete the largest ever clinical trial of MDMA assisted therapy, MAPS now needs more funds. MAPS is raising the money for the last part of their research through a crowd funding campaign on Indiegogo. By contributing, you can help manifest the future of MDMA as a therapeutic medicine - this study will form the basis on which MAPS is planning to build the case for MDMA.
You can find the campaign here: https://www.indiegogo.com/projects/legalizing-psychedelic-therapy/
Check out the video below that shows how MDMA impacted the lives of PTSD sufferers and the potential the study holds: